Get the Stockscreener App
1.18
8.26%
0.09
After Hours:
1.16
-0.02
-1.69%
Vivos Therapeutics Inc stock is traded at $1.18, with a volume of 69,072.
It is up +8.26% in the last 24 hours and down -15.71% over the past month.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
See More
Previous Close:
$1.09
Open:
$1.09
24h Volume:
69,072
Relative Volume:
0.56
Market Cap:
$12.35M
Revenue:
$17.32M
Net Income/Loss:
$-17.10M
P/E Ratio:
-0.5979
EPS:
-1.9737
Net Cash Flow:
$-15.37M
1W Performance:
+2.61%
1M Performance:
-15.71%
6M Performance:
-61.94%
1Y Performance:
-58.60%
1-Day Range:
$1.09
$1.18
1-Week Range:
$1.085
$1.36
52-Week Range:
$1.085
$7.95
Vivos Therapeutics Inc Stock (VVOS) Company Profile
Name
Vivos Therapeutics Inc
Sector
Industry
Phone
(866)908-4867
Address
7921 SOUTHPARK PLAZA,, LITTLETON
Compare VVOS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
1.18 | 11.41M | 17.32M | -17.10M | -15.37M | -1.9737 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Vivos Therapeutics Inc Stock (VVOS) Latest News
Buyback Watch: What are Vivos Therapeutics Incs earnings expectations2026 Recap & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
If You Invested $1,000 in Vivos Therapeutics Inc (VVOS) - stocktitan.net
Vivos Therapeutics Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView
Earnings Risk: Can Vivos Therapeutics Inc withstand a market correction2026 Drop Watch & Breakout Confirmation Alerts - baoquankhu1.vn
Vivos Therapeutics Inc (referred to as Vivos Therapeutics) recently disclosed a comprehensive cost optimization strategy. - Bitget
Vivos Therapeutics gains Nevada insurance network access - Investing.com
Vivos Therapeutics gains Nevada insurance network access By Investing.com - Investing.com India
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market - The Manila Times
Vivos Therapeutics Announces In-Network Insurance Coverage for OSA Treatments in Nevada and Initiates Cost Reduction Measures - quiverquant.com
More Las Vegas sleep apnea patients gain coverage as Vivos cuts costs - stocktitan.net
Aug Swings: Will Vivos Therapeutics Inc benefit from government policy2026 Top Gainers & Community Shared Stock Ideas - baoquankhu1.vn
Decliners Report: Is Vivos Therapeutics Inc in a long term uptrend2026 Fundamental Recap & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
SoundHealth Partners With Vivos Therapeutics to Expand Sleep Tech Access - Medical Product Outsourcing
Vivos Therapeutics (VVOS) to Release Quarterly Earnings on Monday - Defense World
Is Vivos Therapeutics Inc part of any ETFQuarterly Portfolio Report & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Vivos Therapeutics, Inc. Study Affirms Link Between Dental Morphology and Obstructive Sleep Apnea Severity - Quiver Quantitative
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy - GlobeNewswire
Aug Breakouts: Is Vivos Therapeutics Inc part of any ETFFed Meeting & Weekly Top Performers Watchlists - baoquankhu1.vn
Winners Losers: Will Vivos Therapeutics Inc benefit from government policyWeekly Stock Summary & Weekly Return Optimization Plans - baoquankhu1.vn
Bearish Setup: Is Vivos Therapeutics Inc part of any ETF2025 Technical Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn
New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM - ACCESS Newswire
VVOS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Aug Sentiment: Can Vivos Therapeutics Inc maintain its current growth rateChart Signals & Low Drawdown Momentum Ideas - baoquankhu1.vn
Vivos Therapeutics (NASDAQ:VVOS) Stock Price Down 6.7% – Here’s What Happened - Defense World
CEO Moves: What are Complete Solaria Inc Equity Warrants recent SEC filings showingJuly 2025 Technicals & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
What dividend growth rate does Vivos Therapeutics Inc. offerProduct Launch & Low Drawdown Trading Strategies - mfd.ru
New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST) - facilitiesmanagement-now.com
What are Vivos Therapeutics Inc.’s earnings expectationsIPO Watch & Free High Return Stock Watch Alerts - mfd.ru
VVOS Financials: Income Statement, Balance Sheet & Cash Flow | Vivos Therapeutics Inc - stocktitan.net
Retail Surge: Can Vivos Therapeutics Inc maintain its current growth rate2025 Valuation Update & Real-Time Buy Signal Notifications - baoquankhu1.vn
Is Vivos Therapeutics Inc. showing insider buying2025 Price Targets & Verified Swing Trading Watchlists - mfd.ru
VIX Spike: How does Vivos Therapeutics Inc score in quality rankingsEarnings Growth Report & Expert Curated Trade Setups - baoquankhu1.vn
Will Vivos Therapeutics Inc. benefit from government policyDollar Strength & Weekly Top Stock Performers List - mfd.ru
Gap Down: Is Vivos Therapeutics Inc part of any ETF2025 Technical Overview & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Can Vivos Therapeutics Inc. stock hit record highs againJuly 2025 Analyst Calls & High Conviction Buy Zone Alerts - mfd.ru
Earnings Update: How correlated is Vivos Therapeutics Inc to the S P5002025 Macro Impact & Fast Moving Trade Plans - baoquankhu1.vn
Vivos Therapeutics Appoints Gregg Johnson to Board - The Globe and Mail
Vivos Therapeutics Appoints Gregg C. E. Johnson to Board of Directors - TradingView
Vivos Therapeutics, Inc. Appoints Gregg C. E. Johnson as Independent Director of the Board and Compensation Committee of the Board, Effective February 4, 2026 - marketscreener.com
Vivos Therapeutics to Distribute SoundHealth’s FDA-Cleared Sonu and Spatial Sleep Bands - HIT Consultant
Buyout Rumor: Will Vivos Therapeutics Inc benefit from government policyJuly 2025 Final Week & Stock Market Timing Techniques - baoquankhu1.vn
Vivos Therapeutics and SoundHealth collaborate to expand access to groundbreaking FDA-cleared allergy and sleep technologies - marketscreener.com
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies - The Manila Times
Vivos Therapeutics Collaborates with SoundHealth to Enhance Airway and Sleep Health Solutions - Quiver Quantitative
Sound-based allergy and sleep bands join Vivos dentist network - Stock Titan
VIVOS Therapeutics, Inc. ($VVOS) Signs 12-Part Media Series with New to The Street - Eagle-Tribune
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Benzinga
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Receives $4.92 Consensus PT from Brokerages - Defense World
Aug Catalysts: Is Vivos Therapeutics Inc showing insider buyingNew Guidance & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Income Plays: What is the PEG ratio of CHSCNMarket Risk Analysis & Reliable Price Breakout Alerts - baoquankhu1.vn
Vivos Therapeutics Inc Stock (VVOS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):